Gait Training for Concurrent Optimization of Weight Mgt,bp Regulation and Functional Mobility
Sequenced Hybrid Electromechanically Assisted and Conventional Gait Training for Concurrent Optimization of Weight Management, Blood Pressure Regulation, and Functional Mobility in Chronic Stroke Survivors: A Multicenter RCT
1 other identifier
interventional
140
1 country
1
Brief Summary
Stroke is a leading cause of long-term disability and death worldwide, with chronic survivors often experiencing gait disturbances (affecting up to 80%), reduced physical activity, and cardiometabolic comorbidities like obesity and hypertension. These increase risks of recurrent events and diminish quality of life. Electromechanically assisted gait training (EAGT) provides high-intensity, repetitive practice, while conventional gait training (CGT) enhances real-world functional transfer. Evidence gaps exist in the optimal sequencing of these approaches for concurrent improvements in weight management, blood pressure (BP), and mobility, particularly in high-risk chronic stroke populations. This multicenter RCT addresses these gaps by evaluating a sequenced hybrid protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cardiovascular-diseases
Started Jan 2022
Typical duration for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 19, 2026
CompletedFebruary 19, 2026
February 1, 2026
3.4 years
February 4, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome
10 meter walk test to measure functional mobility
Baseline, 6 weeks, 12 weeks
Secondary Outcomes (1)
Secondary outcome
3-month follow-up
Study Arms (3)
Group A (Hybrid: EAGT → CGT)
ACTIVE COMPARATORWeeks 1-6: EAGT (exoskeleton/end-effector devices; 30- 50% body-weight support, speed 1.5-2 km/h, ≥800-1200 steps/session). Weeks 7-12: CGT (overground walking, obstacles, stairs, dual-tasks).
Group B (EAGT-only):
ACTIVE COMPARATORFull 12 weeks EAGT, progressing parameters for intensity.
Group C (CGT-only)
ACTIVE COMPARATORFull 12 weeks CGT, progressing complexity and demands.
Interventions
already mentioned
Group C (CGT-only)
Eligibility Criteria
You may qualify if:
- Ischemic/hemorrhagic stroke ≥6 months prior
- Functional Ambulation Category (FAC) ≥3; BMI ≥25 kg/m²; systolic BP ≥130 mmHg.
- able to provide informed consent
You may not qualify if:
- Unstable cardiovascular conditions
- Severe cognitive impairment (MMSE \<20)
- Other neurological disorders affecting gait
- Musculoskeletal issues limiting training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IQRA National University
Swat, Peshawar, Pakistan
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayman Abdullah Alhammad
Taibah University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 19, 2026
Study Start
January 1, 2022
Primary Completion
June 1, 2025
Study Completion
December 1, 2025
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
due to ethical considerations as per ethical approval document